Particle.news

Download on the App Store

Sensex, Nifty Extend Slide as Pharma, IT Slump on U.S. Drug Tariff Shock

A 100% tariff on branded drug imports announced for October 1 jolted sentiment across exporters.

Overview

  • Benchmarks fell nearly 1% on Friday to 80,426.46 for the Sensex and 24,654.70 for the Nifty, logging a sixth straight losing session.
  • The week was the steepest decline in six months, with the Sensex and Nifty down about 2.5% and roughly ₹15.2 lakh crore in market value erased.
  • President Trump said branded and patented pharmaceutical imports will face a 100% duty from October 1 unless companies are building plants in the U.S., pushing pharma shares lower and the BSE Healthcare index down about 2.14%.
  • IT stocks extended losses on concerns over a steep H‑1B visa fee hike and weaker guidance from Accenture, while mid- and small-cap indices fell more than large caps.
  • Foreign institutional investors were heavy sellers — including ₹4,995.42 crore offloaded on Thursday — as domestic institutions bought selectively without halting the decline.